跳至主要内容
临床试验/ChiCTR-TRC-14004440
ChiCTR-TRC-14004440进行中(未招募)不适用

臨床研究 –「全膝關節置換手術:止血劑的成效與應用」

The Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2014年3月28日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
150
试验地点
1
主要终点
Blood loss after operation, based on the change in haemoglobin level, drain output and wound discharge at baseline and post-operation day 5

研究概览

简要总结

全膝關節置換手術:止血劑的成效與應用

研究设计

研究类型
干预性研究
主要目的
随机平行对照

入排标准

年龄范围
18 至 100(—)
性别
All

入选标准

  • Inclusive criteria are subjects with degenerative osteoarthritis of knee joints, who are scheduled for TKA with posterior stabilized total knee prosthesis.

排除标准

  • are patients with pre-operative anemia with haemoglobin level less than 12 g/dL (reference of PWH lab), known allergy to TNA, deep vein thrombosis, pulmonary embolism, ischemic stroke, those on anticoagulant drugs including warfarin and Plavix, or those undergo TKA under epidural anesthesia, those with renal impairment(with creatinine level >200) and inflammatory arthritic patient.

研究组 & 干预措施

Two groups

To compare the blood-saving effects and risks of developing symptomatic thromboembolic events after total knee arthroplasty by using intra-articular and intravenous tranexamic acid

结局指标

主要结局

Blood loss after operation, based on the change in haemoglobin level, drain output and wound discharge at baseline and post-operation day 5

any symptomatic thromboembolic events after operation at post-operation day 5

次要结局

  • Length of stay in hospital

研究者

研究点 (1)

Loading locations...

相似试验